Replicate Crossover Study Design

Replicate Crossover Study Design is a longitudinal clinical trial methodology in bioequivalence research wherein each participant receives multiple administrations of both test and reference formulations in a randomized sequence across two or more treatment periods, enabling the separate estimation of within-subject variability for test and reference products through repeated measurements on the same subjects.

492

Publications

21.2K

Citations

2.6K

Authors

893

Institutions

Publications per year

2017–2026

119

Variants

Replicate Crossover Design

Authors

2.6K

  1. KY
    Kyung‐Sang Yu

    Seoul National University Hospital, South Korea

    7 publications · 153 citations

    7

    h-index

  2. IJ
    In‐Jin Jang

    Seoul National University Hospital, South Korea

    6 publications · 142 citations

    6

    h-index

  3. SS
    Sang-Goo Shin

    Seoul National University Hospital, South Korea

    5 publications · 107 citations

    5

    h-index

  4. BK
    Bo‐Hyung Kim

    Seoul National University Hospital, South Korea

    4 publications · 96 citations

    4

    h-index

  5. JC
    Joo‐Youn Cho

    Seoul National University Hospital, South Korea

    4 publications · 90 citations

    4

    h-index

1–5 of 2.6K

Venues

  1. Clinical Therapeutics

    43 publications · 1.2K citations

    21

    h-index

  2. Journal of Animal Science

    23 publications · 847 citations

    16

    h-index

  3. American Journal of Veterinary Research

    AJVR · 11 publications · 485 citations

    11

    h-index

  4. PubMed

    Repository · 12 publications · 536 citations

    10

    h-index

  5. American Journal of Clinical Nutrition

    AJCN · 8 publications · 671 citations

    8

    h-index

1–5